4.4 Article

Changes in drug 13C NMR chemical shifts as a tool for monitoring interactions with DNA

Journal

BIOPHYSICAL CHEMISTRY
Volume 109, Issue 3, Pages 333-344

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bpc.2003.12.005

Keywords

netropsin; ligand; nuclear magnetic resonance (NMR); deoxyribo nucleic acid (DNA); drug; chemical shift; carbon; inhibitor

Ask authors/readers for more resources

The antibiotic drug, netropsin, was complexed with the DNA oligonucleotide duplex [d(GGTATACC)](2) to monitor drug C-13 NMR chemical shifts changes. The binding mode of netropsin to the minor groove of DNA is well-known, and served as a good model for evaluating the relative sensitivity of 13C chemical shifts to hydrogen bonding. Large downfield shifts were observed for four resonances of carbons that neighbor sites which are known to form hydrogen bond interactions with the DNA minor groove. Many of the remaining resonances of netropsin exhibit shielding or relatively smaller deshielding changes. Based on the model system presented here, large deshielding NMR shift changes of a ligand upon macromolecule binding can likely be attributed to hydrogen bond formation at nearby sites. (C) 2003 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available